AXP vs FLGT · P/E 20, rev $21.73B vs rev $156.5M
American Express Company (AXP) versus Fulgent Genetics Inc (FLGT) — a side-by-side from cached financials, not a winner call.
American Express Company (AXP) is a credit services company listed on US. It is led by Stephen Joseph Squeri.
Fulgent Genetics Inc (FLGT) is a diagnostics & research company listed on US.
Latest reported AXP revenue for 2026-06-30 was $21.73B. Net income was $6.08B. AXP currently screens at market cap $215.94B and trailing P/E 19.8.
Latest reported FLGT revenue for 2026-06-30 was $156.5M. Net income was -$54.4M. FLGT currently screens at market cap $586.6M.
AXP currently screens at market cap $215.94B and trailing P/E 19.8. FLGT currently screens at market cap $586.6M.
Not investment advice. Open the AXP and FLGT stock pages for the full models.
Not investment advice.